Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yancheng Suhai Pharmaceutical is a China-based pharmaceutical company specializing in the development, production, and sale of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. Located in the Yancheng Environmental Protection Industrial Park, the company is a major manufacturer of psychiatric and neurological medications, most notably Chlorpromazine Hydrochloride and Promethazine Hydrochloride. Their facilities are GMP-certified, enabling the production of various formulations including tablets and injections for both domestic and international markets. The company is recognized as a high-tech enterprise in Jiangsu Province, focusing on high-quality chemical synthesis and the large-scale manufacturing of essential generic medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yancheng Suhai Pharmaceutical.